Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.
Tell us about a missing company
Jeil Pharmaceutical Co., Ltd. clinical trials
Part of Jeil Pharma Holdings Inc., which holds 49.24% as of 2025-12-31. Source
The registry lists 55 studies whose lead sponsor is Jeil Pharmaceutical Co., Ltd. or one of 1 company grouped under it. 11 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 15, 2026.
Keep track of what changes. Save the Jeil Pharmaceutical Co., Ltd. studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesRegistry sponsor names on this page
Each name exactly as ClinicalTrials.gov lists it, and how it relates to Jeil Pharmaceutical Co., Ltd..
- Jeil Pharmaceutical Co., Ltd.36 studiesSame company
Something wrong?
- Onconic Therapeutics Inc.19 studies →Subsidiary
Something wrong?
Studies
Recruiting first, then most recently updated. Showing 50 of 55. Browse all 55 →
- Efficacy and Safety of JP-1366-based Triple Therapy in Helicobacter Pylori-positive SubjectsNot yet recruitingNCT07875933Phase 3
Sponsor listed in the registry: Onconic Therapeutics Inc.
- Phase 3 Study of JP-1366: Efficacy and Safety of JP-1366 as Maintenance Therapy in Subjects With Healed Erosive EsophagitisNot yet recruitingNCT07732075Phase 3
Sponsor listed in the registry: Onconic Therapeutics Inc.
- Food and Ethnicity Effects on Pharmacokinetics and Safety of JPI-547 in Healthy Male ParticipantsNot yet recruitingNCT07570186Phase 1
Sponsor listed in the registry: Onconic Therapeutics Inc.
- Study to Assess the Safety, Tolerability of JPI-547 in Combination With Modified FOLFIRINOX or Gemcitabine-nab-paclitaxel in Patients With Locally Advanced and Metastatic Pancreatic CancerRecruitingNCT05257993Phase 1/2
Sponsor listed in the registry: Onconic Therapeutics Inc.
- To Evaluate the Efficacy and Safety of JPI-547 in Combination With Bevacizumab as Maintenance Therapy in Relapsed Ovarian CancerNot yet recruitingNCT07370818Phase 2
Sponsor listed in the registry: Onconic Therapeutics Inc.
- To Evaluate the Safety and Tolerability of Study Drug as a Third-line and Beyond Therapy for Recurrent or Metastatic Gastric CancerNot yet recruitingNCT07364422Phase 1/2
Sponsor listed in the registry: Onconic Therapeutics Inc.
- to Evaluate the Safety and the Pharmacokinetic and Pharmacodynamic Interactions Between JP-1366 and Clopidogrel, Aspirin, Atorvastatin and ApixabanRecruitingNCT07265466Phase 1
Sponsor listed in the registry: Onconic Therapeutics Inc.
- Phase 3 Study of JP-1366: Efficacy and Safety of JP-1366 in Patients With Non-erosive Gastroesophageal Reflux DiseaseNot yet recruitingNCT07160790Phase 3
Sponsor listed in the registry: Onconic Therapeutics Inc.
- JAQBO® Tab. 20 mg(Zastaprazan Citrate) in Erosive GERDNot yet recruitingNCT07115706
- Study to Evaluate the Efficacy and Safety of JP-1366 in the Prevention of NSAIDs-Induced Peptic UlcersRecruitingNCT06439563Phase 3
Sponsor listed in the registry: Onconic Therapeutics Inc.
- To Evaluate the Safety, Pharmacokinetic Characteristics and the Effect of Food After Administration of JLP-2004RecruitingNCT06431399Phase 1
- Evaluation of Efficacy and Safety When Administered JP-2266 in Type 2 Diabetes PatientsCompletedNCT06144788Phase 2
- Phase 1 Study of JLP-2302 and JP-1366: PK and Safety in Healthy VolunteersCompletedNCT07181538Phase 1
Sponsor listed in the registry: Onconic Therapeutics Inc.
- Observationa Study is a Prospective and Multi-institutional Observational Study.CompletedNCT06952855
- JP-1366 20mg Versus Esomeprazole 40mg in Patients With Erosive EsophagitisCompletedNCT05443984Phase 3
Sponsor listed in the registry: Onconic Therapeutics Inc.
- A Study to Evaluate the Efficacy and Safety of JPI-547 in Platinum-resistant, Advanced/Relapsed Ovarian Cancer Subjects Previously Treated With a PARP InhibitorActive, not recruitingNCT05475184Phase 2
Sponsor listed in the registry: Onconic Therapeutics Inc.
- Clinical Trial to Evaluate the Efficacy and Safety of JP-1366 in Patients With Gastric UlcerCompletedNCT05448001Phase 3
Sponsor listed in the registry: Onconic Therapeutics Inc.
- Clinical Trial to Evaluate Food-Effects on Pharmacokinetics and Pharmacodynamics of Oral Single Dose of JP-1366 Tablet in Healthy VolunteersCompletedNCT05712681Phase 1
Sponsor listed in the registry: Onconic Therapeutics Inc.
- To Evaluate the Safety and Pharmacokinetic Characteristics After the Administration of JC-001 and JLP-1901CompletedNCT06171880Phase 1
- To Evaluate the Safety and Pharmacokinetic Characteristics After Multiple Administration of JC-013 and JLP-2004CompletedNCT06169059Phase 1
- To Evaluate the Safety and Pharmacokinetic Characteristics After the Administration of JT-001, JT-002 and JLP-2008CompletedNCT06165965Phase 1
- Clinical Trial to Evaluate the Safety and Pharmacokinetics of JP-1366 in Healthy Adult VolunteersCompletedNCT05814809Phase 1
Sponsor listed in the registry: Onconic Therapeutics Inc.
- A Study of Lubiprostone to Treat ConstipationStatus unknownNCT04861233
- Clinical Trial to Evaluate the Safety and Efficacy of JP-1366 in Patients With Erosive Gastroesophageal Reflux DiseaseCompletedNCT04282954Phase 2
Sponsor listed in the registry: Onconic Therapeutics Inc.
- Compare Pharmacokinetics and Safety of JP-1366 Between Korean and CaucasianCompletedNCT05181124Phase 1
Sponsor listed in the registry: Onconic Therapeutics Inc.
- A Study of NOV140201 (JPI-547) in Subject With Advanced Solid TumorsCompletedNCT04335604Phase 1
Sponsor listed in the registry: Onconic Therapeutics Inc.
- To Evaluate the Efficacy and Safety of JT-003 add-on in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin and DapagliflozinStatus unknownNCT05296044Phase 3
- To Evaluate the Efficacy and Safety of JT-001 add-on in Paatients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin and DapagliflozinStatus unknownNCT05101135Phase 3
- To Evaluate the Efficacy and Safety of JLP-2002 on Symptoms of Overactive BladderCompletedNCT04917315Phase 3
- Drug-drug Interactions and Safety Among JP-1366, Amoxicillin, and Clarithromycin in Healthy VolunteersCompletedNCT05194046Phase 1
Sponsor listed in the registry: Onconic Therapeutics Inc.
- Safety, Tolerability, and Pharmacokinetic and Pharmacodynamic Characteristics of JP-2266 in Healthy SubjectsStatus unknownNCT05172622Phase 1
- The Safety and PK Characteristics of the Co-administration of JLP-2002 and Comparator in Healthy VolunteersCompletedNCT04914221Phase 1
- Clinical Trial to Evaluate the Efficacy and Safety of JPI-289 in Patients With Acute Ischemic StrokeStatus unknownNCT03062397Phase 2
- Clinical Trial to Compare the Solifenacin/Tamsulosin Combination Therapy With Tamsulosin Monotherapy for LUTS Due to BPHCompletedNCT02972268Phase 3
- The PK Characteristics of the Co-administration of Rosuvastatin and Telmisartan/Amlodipine and JLP-1401 in Healthy Adult Volunteers VolunteersCompletedNCT03707899Phase 1
- Clinical Trial to Investigate the Safety, Tolerability and Pharmacokinetics and Pharmacodynamics of JP-1366 Oral Administration in Healthy Male SubjectsCompletedNCT03383042Phase 1
- The PK Characteristics of the Co-administration of Metformin SR and Rosuvastatin and JLP-1310 in Healthy Male Volunteers.CompletedNCT03690778Phase 1
- Clinical Trial to Evaluate the Efficacy and Safety of UNI-DEB for Unresectable Hepatocellular CarcinomaCompletedNCT03533920Not applicable
- Metformin/Rosuvastatin Combination Therapy With in Patients With Type 2 Diabetes and DyslipidemiaCompletedNCT02827903Phase 3
- Study to Evaluate the Efficacy and Safety of Telmisartan/Amlodipine/RosuvastatinCompletedNCT03088254Phase 3
- Pilot Clinical Trial to Evaluate the UNI-DEB for Unresectable Hepatocellular CarcinomaCompletedNCT03564405Not applicable
- Investigate the Effect of Food on the Pharmacokinetics of JLP-1310 in Healthy Male VolunteersCompletedNCT02449187Phase 1
- The PK Characteristics of the Co-administration of Metformin SR and Rosuvastatin and JLP-1310 in Healthy Male VolunteersCompletedNCT02982798Phase 1
- Clinical Trial to Investigate the Pharmacokinetics Drug Interaction Between Metformin and RosuvastatinCompletedNCT02186483Phase 1
- Drug-drug Interaction Following Oral Administration of Telmisartan/Amlodipine and Atorvastatin in Healthy Adult VolunteersCompletedNCT03461081Phase 1
- The PK Characteristics of the Co-administration of Rosuvastatin and Telmisartan/Amlodipine and JLP-1401 in Healthy Male Volunteers VolunteersCompletedNCT03247140Phase 1
- Compare the Pharmacokinetic Characteristics and the Safety Between Zeropix and Champix in Healthy Adult Male Subjects.CompletedNCT03362008Phase 1
- Trial to Assess the Efficacy of Combination Formula of Aspirin Plus Clopidogrel in Patients With Coronary StentCompletedNCT02410083Phase 4
- Clinical Trial to Evaluate the Efficacy and the Safety of Antihypertensive TabletsCompletedNCT00553865Phase 2
- Investigate the Effect of Food on the Pharmacokinetic of JLP-1207 in Healthy Male VolunteersCompletedNCT02447367Phase 1